DLL4 mouse monoclonal antibody, clone 4A11F8/4A11G2, Purified
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
DLL4 mouse monoclonal antibody, clone 4A11F8/4A11G2, Purified
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Rabbit Polyclonal Anti-DLL4 Antibody
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | Fusion protein of human DLL4 |
DLL4 rabbit polyclonal antibody, Purified
Applications | ELISA, IHC, WB |
Reactivities | Human, Monkey, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide corresponding to the internal region of human DLL4. |
DLL4 rabbit polyclonal antibody
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | Fusion protein of human DLL4 |
DLL4 rabbit polyclonal antibody, Biotin
Applications | ELISA, WB |
Reactivities | Human |
Conjugation | Biotin |
Immunogen | Highly pure HEK293 cells derived Recombinant Human sDLL-4 (Cat.-No AR31113PU-N). |
Rabbit polyclonal anti-DELTA-4 antibody
Applications | IHC, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Anti-DELTA-4 antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to an internal region of Human DELTA-4. |
DLL4 rabbit polyclonal antibody, Biotin
Applications | ELISA, WB |
Reactivities | Human |
Conjugation | Biotin |
Immunogen | Highly pure HEK293 cells derived Recombinant Human sDLL-4 (Cat.-No AR31113PU-N). |
DLL4 mouse monoclonal antibody, clone MHD4-46, Purified
Applications | FC, FN |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-DLL4 Reference Antibody (navicixizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Conjugation | Unconjugated |
Anti-DLL4 Reference Antibody (enoticumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-DLL4 Reference Antibody (demcizumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Mouse |
Conjugation | Unconjugated |
Goat Anti-DLL4 Antibody
Applications | WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Immunogen | Peptide with sequence KNTNQKKELEVDC, from the internal region of the protein sequence according to NP_061947.1. |
Rabbit polyclonal Anti-DLL4 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-DLL4 antibody: synthetic peptide directed towards the N terminal of human DLL4. Synthetic peptide located within the following region: PGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIE |
Rabbit polyclonal Anti-DLL4 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-DLL4 antibody: synthetic peptide directed towards the N terminal of human DLL4. Synthetic peptide located within the following region: QGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHF |